All Type of News
Doctors are positive about the SGLT-2 inhibitor…“Yet, it lacks in patient cases”
The treatment industry for ‘diabetes’, considered as one of the chronic diseases, has begun a new changing era. So far, the existing diabetes treatments have had side effects of weight increases and hypoglycemia.
How...
The government pushes forward the management of non-pharmaceutical product for electronic cigarette liquids
As the nationwide interest increases towards antismoking, the Ministry of Food and Drug Safety (Minister Seung Jung)pre-announced an amendment of the ‘Indicated Range of Non-Pharmaceutical Products’to manage ‘liquefie...
The Ministry of Health and Welfare will invest KRW 511.7 billion on R&D
The Ministry of Health and Welfare (MHW) will invest KRW 511.7 billion on R&D (Research and Development) this year.
The MHW held the Health Technology Policy Deliberation Committee (chairwoman:professor Sun-young Kim...
While sales of Insadol went ‘-12%’, Fulcare were increased by 400%
Last year, it is shown that sales of the Dongkook Pharmaceutical’s Insadolhave been hesitated, but the Menarini’sFulcare and the Ildong Pharmaceutical’s Aronamin Gold took a step forward.
However, sales of the Insado...
The effect of Ezatimibecaused improved confidence…Atozet will be launched in Korea soon
It is noticed that a new hyperlipidemia complex drug will soon be launched as interconnecting with the research report proving effectiveness of non-statin type medicines on treating cardiovascular disorders.
Accordin...
Bayer Korea appointed CEO Ingrid U. Drechsel as the new chief
Bayer Korea announced that it will appoint Ingrid U. Drechsel to the new CEO of Bayer Korea since 1 February 2015.
Shewill all the divisions of Bayer Korea, including Bayer Healthcare, Crop Science and Material Scien...
There were 33,540 pharmaceutical patents in Korea for the past 7 years
The Korea Health Industry Development Institute (KHIDI)recently released a report titled ‘Trend Analysis Regarding the Healthcare Industry Using Domestic Patent Information’publicize the domestic pharmaceutical patent...
Will personnel typhoon occur in the pharmaceutical industry?... CEOs of 7 companies will be expired in their contracts
Along with the General Meeting on this March, the industry has paid attention in which professional managers of 7 listed pharmaceutical companies are expected to be expired in their contracts.
Although 10 professiona...
The poor performance report of top pharmaceutical companies on the fourth quarter… both in sales and profits
It is analyzed performances of the top 4 listed pharmaceutical companies in sales were slowed down.
Declined market shares of the top pharmaceutical companies can be explained byadvances of mid-sized pharmaceutical c...
Handok Teva recorded the lowest price in generics of Baraclude exceeding Hanmi
Generics of the hepatitis type B treatment Baracludes (entecavir), which recorded the most prescription expenses, have competed fiercely to register low prices.
As Hanmi Pharmaceutical volunteered to reduce its drug ...
